{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:12:01Z","timestamp":1775081521999,"version":"3.50.1"},"reference-count":16,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:p>Here a young patient (&lt; 21 years of age) with a history of infective dermatitis is described. The patient was diagnosed with myelopathy associated with HTLV-1\/tropical spastic paraparesis and treated with interferon beta-1a. The disease was clinically established as HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP), and laboratory tests confirmed the presence of antibodies to HTLV-1 in the cerebrospinal fluid (CSF). Mumps, cytomegalovirus, Epstein-Barr virus, schistosomiasis, herpes virus 1 and 2, rubella, measles, varicella-zoster toxoplasmosis, hepatitis, HIV, and syphilis were excluded by serology. The patient was diagnosed with neurogenic bladder and presented with nocturia, urinary urgency, paresthesia of the lower left limb, a marked reduction of muscle strength in the lower limbs, and a slight reduction in upper limb strength. During the fourth week of treatment with interferon beta-1a, urinary urgency and paresthesia disappeared and clinical motor skills improved.<\/jats:p>","DOI":"10.1590\/s0036-46652014000500013","type":"journal-article","created":{"date-parts":[[2014,9,13]],"date-time":"2014-09-13T14:30:31Z","timestamp":1410618631000},"page":"443-445","source":"Crossref","is-referenced-by-count":7,"title":["INTERFERON BETA-1A TREATMENT IN HTLV-1-ASSOCIATED MYELOPATHY\/TROPICAL SPASTIC PARAPARESIS: A CASE REPORT"],"prefix":"10.1590","volume":"56","author":[{"given":"Gra\u00e7a Maria de Castro","family":"Viana","sequence":"first","affiliation":[{"name":"Universidade Federal do Maranh\u00e3o,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos Antonio Cust\u00f3dio Neto da","family":"Silva","sequence":"additional","affiliation":[{"name":"Universidade Federal do Maranh\u00e3o,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Lima","family":"Souza","sequence":"additional","affiliation":[{"name":"Universidade Federal do Maranh\u00e3o,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nat\u00e1lia Barbosa da Silva","family":"Lopes","sequence":"additional","affiliation":[{"name":"Universidade Federal do Maranh\u00e3o,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego Luz Felipe da","family":"Silva","sequence":"additional","affiliation":[{"name":"Universidade Federal do Maranh\u00e3o,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria do Desterro Soares Brand\u00e3o","family":"Nascimento","sequence":"additional","affiliation":[{"name":"Universidade Federal do Maranh\u00e3o,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","series-title":"Cadernos Hemominas HTLV","first-page":"228","volume-title":"Avan\u00e7os e perspectivas na terap\u00eautica das doen\u00e7as associadas \u00e0 infec\u00e7\u00e3o por HTLV","author":"Ara\u00fajo A","year":"2006","edition":"4a ed"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1590\/S1413-86702009000100003","article-title":"Frequency of mental disturbances in HTLV-1 patients in the state of Bahia, Brazil","volume":"13","author":"Carvalho AGJ","year":"2009","journal-title":"Braz J Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1590\/S0102-311X2005000300027","article-title":"Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV I\/II): serological screening prevalence rates in blood donors from large urban areas in Brazil","volume":"21","author":"Catalan-Soares B","year":"2005","journal-title":"Cad Sa\u00fade P\u00fablica"},{"key":"ref4","first-page":"1","article-title":"Interferon beta-1a improves urinary symptoms, reduces proviral load, and modifies the immune response in a patient with HAM\/TSP. Case Rep Neurol Med","author":"Costa DT","year":"2012","journal-title":"2012"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1590\/S0100-879X2010007500138","article-title":"Clinical and immunological features of patients with atopy and concomitant HLTV-1 infection","volume":"43","author":"Gaspar-Sobrinho FP","year":"2010","journal-title":"Braz J Med Biol Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1590\/S1676-24442009000200003","article-title":"Diagn\u00f3stico laboratorial da mielopatia associada ao HTLV-I: m\u00e9todos para an\u00e1lise do l\u00edquido cefalorraquidiano","volume":"45","author":"Gon\u00e7alves CCA","year":"2009","journal-title":"J Bras Patol Med Lab"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ana.410390304","article-title":"Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)","volume":"39","author":"Jacobs LD","year":"1996","journal-title":"Ann Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1600-0404.1992.tb08059.x","article-title":"Systemic interferon-alpha in the treatment of HTLV-I-associated myelopathy","volume":"86","author":"Kuroda Y","year":"1992","journal-title":"Acta Neurol Scand"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/ana.20429","article-title":"Interferon-?1 a therapy in human T-lymphotropic virus type I-associated neurologic disease","volume":"57","author":"Oh U","year":"2005","journal-title":"Ann Neurol"},{"issue":"(9139)","key":"ref10","first-page":"1498","article-title":"PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group","volume":"352","author":"Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing\/remitting multiple sclerosis","year":"1998","journal-title":"Lancet"},{"key":"ref11","first-page":"230","article-title":"VHC e HTLV-I: aspectos cl\u00ednicos e epidemiol\u00f3gicos da co-infec\u00e7\u00e3o","volume":"2","author":"R\u00eago A","year":"2003","journal-title":"Rev Cienc M\u00e9d Biol (Salvador)"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1590\/S0037-86822002000400015","article-title":"Mielopatia associada ao v\u00edrus linfotr\u00f3pico humano de c\u00e9lulas T do tipo 1 (HTLV-1)","volume":"35","author":"Ribas JGR","year":"2002","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1086\/380101","article-title":"Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I associated myelopathy\/tropical spastic paraparesis","volume":"189","author":"Saito M","year":"2004","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1590\/S1676-24442005000200008","article-title":"Epidemiologia, fisiopatogenia e diagn\u00f3stico laboratorial da infec\u00e7\u00e3o pelo HTLV-I","volume":"41","author":"Santos FLN","year":"2005","journal-title":"J Bras Patol Med Lab"},{"key":"ref15","series-title":"Introdu\u00e7\u00e3o\u2019\u00e0\u2019virologia humana. 2<sup>a<\/sup> ed","first-page":"290","volume-title":"Viroses multissist\u00eamicas","author":"Santos NSO","year":"2008"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0022-510X(96)05319-1","article-title":"Long term, high dose interferon-alpha treatment in HTLV-I-associated myelopathy\/tropical spastic paraparesis: a combined clinical, virological and immunological study","volume":"147","author":"Yamasaki K","year":"1997","journal-title":"J Neurol Sci"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rimtsp\/v56n5\/0036-4665-rimtsp-56-05-443.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T17:23:05Z","timestamp":1495905785000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652014000500443&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0036-46652014000500443"],"URL":"https:\/\/doi.org\/10.1590\/s0036-46652014000500013","relation":{},"ISSN":["0036-4665"],"issn-type":[{"value":"0036-4665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}